Here are what the editors at HealthDay consider to be the most important developments in OBGYN & Women’s Health for April 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Coronary Vessel Wall Thickness Surrogate […]
Read More
Variants are associated with reproductive and metabolic traits in PCOS families
Read More
By Linda Carroll (Reuters Health) – Most states have statutes that invalidate a...
Read More
No evidence seen for benefits of screening nonpregnant women or men for asymptomatic bacteriuria
Read More
Rate of hepatic tumors higher among children conceived via IVF
Read More
Remaining manufacturers have failed to prove the long-term safety or benefit of their devices
Read More
Women in CBT group had greater reductions in insomnia severity, were likely to have remission
Read More
Risk for developing pediatric diabetes increased in offspring from birth through age 22 years
Read More
But no significant differences seen in gestational DM risk between metformin users, nonusers
Read More
